Skyhawk Therapeutics Expands Leadership Team, Appointing Elliot Ehrich MD as President and Graeme Smith PhD as SVP NonClinical Development
Skyhawk Therapeutics Expands Leadership Team, Appointing Elliot Ehrich MD as President and Graeme Smith PhD as SVP NonClinical Development News provided by Share this article Share this article Elliot Ehrich MD brings 25+ years R&D and clinical development leadership experience to the company; Graeme Smith PhD DABT brings 15+ years of nonclinical drug development leadership experience to the company. WALTHAM, Mass., April 13, 2021 /PRNewswire/ -- Skyhawk Therapeutics today announced the appointments of Dr. Elliot Ehrich as its President, and Dr. Graeme Smith as its Senior Vice President of N...
Source: prnewswire.com